214 related articles for article (PubMed ID: 7928264)
1. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
Dean KI; Komu M; Dean PB; Kormano M
Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
[No Abstract] [Full Text] [Related]
2. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
Klengel S; Hietschold V; Schreiber M; Köhler K
Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
[No Abstract] [Full Text] [Related]
4. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
[TBL] [Abstract][Full Text] [Related]
5. Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma.
Kusumoto M; Kono M; Adachi S; Yamasaki K; Itouji E; Sakai E; Endo M; Nakamura T; Kimura K
Invest Radiol; 1994 Jun; 29 Suppl 2():S255-6. PubMed ID: 7928249
[No Abstract] [Full Text] [Related]
6. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
Kleinman PK; Ragland RL
AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
[No Abstract] [Full Text] [Related]
7. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
8. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
9. Effect of gadopentetate dimeglumine on proton magnetization transfer in protein solutions and tissues at 0.1 Tesla.
Kormano M; Komu M; Niemi P; Virta A
Invest Radiol; 1994 Jun; 29 Suppl 2():S247-8. PubMed ID: 7523328
[No Abstract] [Full Text] [Related]
10. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
11. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
Brasch RC; Schwickert HC; Roberts TP; Shames DM; van Dijke CF; Mann JS; Demsar F
Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
[No Abstract] [Full Text] [Related]
12. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
[No Abstract] [Full Text] [Related]
13. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
[TBL] [Abstract][Full Text] [Related]
14. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
[No Abstract] [Full Text] [Related]
15. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
16. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
Niendorf HP; Alhassan A; Geens VR; Clauss W
Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
[No Abstract] [Full Text] [Related]
17. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures?
Bronen RA
AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999
[No Abstract] [Full Text] [Related]
18. Technical note: magnetic resonance imaging-guided pre-operative breast localization using "freehand technique".
Brenner RJ; Shellock FG; Rothman BJ; Giuliano A
Br J Radiol; 1995 Oct; 68(814):1095-8. PubMed ID: 7496711
[TBL] [Abstract][Full Text] [Related]
19. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
Turkat TJ; Klein BD; Polan RL; Richman RH
J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
[TBL] [Abstract][Full Text] [Related]
20. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
